NCT07930091
Molecular Biomarkers for Discriminating Lupus Nephritis in SLE
StatusNot Yet Recruiting
PhaseNot specified
SponsorEgyptian Chinese University
Primary completion (estimated)
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗
- Minor Secondary endpoints: 1 to 2
- Study First Submitted
- Minor: routine updates
Endpoints
Primary
Discriminatory performance of the predefined molecular biomarker panel for distinguishing SLE patients with established LN from those without LN
Timeframe: baseline at day 1
Secondary (2)
Correlation of molecular biomarkers with SLE disease activity
Correlation of molecular biomarkers with SLICC/ACR-DI
Arms and interventions
Group 1: SLE with Lupus Nephritis
Patients with established systemic lupus erythematosus and established lupus nephritis.
Group 2: SLE without Lupus Nephritis
Patients with established systemic lupus erythematosus without lupus nephritis.
Diagnostic tests: predefined molecular biomarker panel